Pharmaceutical industry: GSK is negotiating a billion-dollar purchase of the cancer specialist Nuvalent

—·1d

The British pharmaceutical giant wants to expand its oncology portfolio with the takeover of the US biotech. It would be an early success for the new CEO Miels.

TickersGSK, USChannelssemiconductors, stocksCountriesgermany, europeCategoriesmergers-acquisitions

Open original source ↗

Published

6/9/2026, 5:10:50 AM

Fetched

6/9/2026, 6:07:08 AM

Confidence

60 / 100

Relevance

44 / 100

Trust

—

Language